HCM II Acquisition Corp. Files 8-K with Business Updates

TL;DR

HCM II Acquisition Corp. filed an 8-K on Aug 20th detailing material agreements, equity sales, and a fiscal year change to Dec 31st.

AI Summary

On August 15, 2024, HCM II Acquisition Corp. entered into a material definitive agreement related to its business operations. The company also reported on unregistered sales of equity securities and amendments to its articles of incorporation or bylaws. The filing indicates a change in fiscal year, with the new fiscal year ending on December 31st.

Why It Matters

This 8-K filing provides crucial updates on HCM II Acquisition Corp.'s corporate structure and financial activities, which could impact investor decisions.

Risk Assessment

Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can carry inherent risks and require careful investor due diligence.

Key Numbers

• 1231 — Fiscal Year End (The company's fiscal year will now end on December 31st.)

Key Players & Entities

• HCM II Acquisition Corp. (company) — Registrant
• August 15, 2024 (date) — Earliest event reported
• August 20, 2024 (date) — Date of report
• December 31st (date) — New fiscal year end

FAQ

Key Financial Figures

• $0.0001 — AQ Class A Ordinary Shares, par value $0.0001 per share HOND NASDAQ Redeemable
• $11.50 — ne Class A ordinary share at a price of $11.50 per share HONDW NASDAQ Indicate b
• $10.00 — hare. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to
• $230,000,000 — rating gross proceeds to the Company of $230,000,000. In connection with the IPO, the Compa
• $1.00 — the Underwriter at a purchase price of $1.00 per Private Placement Warrant, generati
• $6,850,000 — rating gross proceeds to the Company of $6,850,000. The Private Placement Warrants are ide
• $231,150,000 — Item 8.01. Other Events. A total of $231,150,000, of the proceeds from the IPO and the P
• $10,720,000 — acement Warrants (which amount includes $10,720,000 of the underwriter's deferred discount)
• $100,000 — he Company to pay its taxes (less up to $100,000 interest to pay dissolution expenses),

Filing Documents

• ny20027439x13_8k.htm (8-K) — 54KB
• ny20027439x13_ex1-1.htm (EX-1.1) — 273KB
• ny20027439x13_ex3-1.htm (EX-3.1) — 397KB
• ny20027439x13_ex4-1.htm (EX-4.1) — 179KB
• ny20027439x13_ex10-1.htm (EX-10.1) — 123KB
• ny20027439x13_ex10-2.htm (EX-10.2) — 136KB
• ny20027439x13_ex10-3a.htm (EX-10.3(A)) — 57KB
• ny20027439x13_ex10-3b.htm (EX-10.3(B)) — 101KB
• ny20027439x13_ex10-4.htm (EX-10.4) — 57KB
• ny20027439x13_ex10-5.htm (EX-10.5) — 19KB
• ny20027439x13_ex99-1.htm (EX-99.1) — 8KB
• ny20027439x13_ex99-2.htm (EX-99.2) — 7KB
• 0001140361-24-037870.txt ( ) — 1871KB
• hcma-20240815.xsd (EX-101.SCH) — 5KB
• hcma-20240815_def.xml (EX-101.DEF) — 19KB
• hcma-20240815_lab.xml (EX-101.LAB) — 29KB
• hcma-20240815_pre.xml (EX-101.PRE) — 21KB
• ny20027439x13_8k_htm.xml (XML) — 8KB

01

Item 1.01. Entry into a Material Definitive Agreement. On August 19, 2024, HCM II Acquisition Corp. (the " Company ") consummated its initial public offering (the " IPO ") of 23,000,000 units, including 3,000,000 units issued pursuant to the full exercise of the underwriter of its over-allotment option (the " Units "). Each Unit consists of one Class A ordinary share, par value $0.0001 per share (" Class A Ordinary Shares "), and one-half of one redeemable warrant of the Company (" Warrant "), with each whole Warrant entitling the holder thereof to purchase one Class A ordinary share for $11.50 per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000. In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company's Registration Statement on Form S-1 (File No. 333-280283) related to the IPO, originally filed with the U.S. Securities and Exchange Commission (the " Commission ") on June 18, 2024 (as amended, the " Registration Statement "): An Underwriting Agreement, dated August 15, 2024, by and among the Company, Cantor Fitzgerald & Co. (the " Underwriter "), a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference. A Warrant Agreement, dated August 15, 2024, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference. An Investment Management Trust Agreement, dated August 15, 2024, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference. A Registration Rights Agreement, dated August 15, 2024, by and among the Company, the Company's sponsor, HCM Investor Holdings II, LLC (the " Sponsor ") and the Underwriter, a copy of which is attached as Exhibit 10.2 here

02

Item 3.02. Unregistered Sales of Equity Securities. Simultaneously with the closing of the IPO, pursuant to the Warrant Purchase Agreements, the Company completed the private sale of an aggregate of 6,850,000 warrants (the " Private Placement Warrants ") to the Sponsor and the Underwriter at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $6,850,000. The Private Placement Warrants are identical to the Warrants included in the Units sold as part of the Units in the IPO, except as otherwise disclosed in the Registration Statement. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

03

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The Company's Amended and Restated Memorandum and Articles of Association (the " Memorandum and Articles ") was approved on August 15, 2024. A description of the Memorandum and Articles is contained in the section of the prospectus, dated August 15, 2024 pursuant to Rule 424(b) under the Securities Act (the " Prospectus "), entitled "Description of Securities" and is incorporated herein by reference. The description is qualified in its entirety by reference to the full text of the Memorandum and Articles, which is attached as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated into this Item 5.03 by reference.

01

Item 8.01. Other Events. A total of $231,150,000, of the proceeds from the IPO and the Private Placement Warrants (which amount includes $10,720,000 of the underwriter's deferred discount), was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay its taxes (less up to $100,000 interest to pay dissolution expenses), the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company's initial business combination, (ii) the redemption of any of the Company's public shares properly submitted in connection with a stockholder vote to amend the Company's amended and restated certificate of incorporation (a) to modify the substance or timing of its obligation to redeem 100% of the Company's public shares if it does not complete its initial business combination within 24 months from the closing of the IPO or (b) with respect to any other provision relating to stockholders' rights or pre-initial business combination activity and (iii) the redemption of the Company's public shares if it is unable to complete its initial business combination within 24 months from the closing of the IPO, subject to applicable law. On August 15, 2024, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K. On August 19, 2024, the Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits The following exhibits are being filed herewith: Exhibit No. Description 1.1 Underwriting Agreement, dated August 15, 2024, by and between the Company and Cantor Fitzgerald & Co. 3.1 Amended and Restated Memorandum and Articles of Association. 4.1 Warrant Agreement, dated August 15, 2024, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent. 10.1 Investment Management Trust Agreement, dated August 15, 2024, by and between the Company and Continental Stock Transfer & Trust Company, as trustee. 10.2 Registration Rights Agreement, dated August 15, 2024, by and among the Company, the Sponsor and the Underwriter. 10.3(a) Private Placement Warrants Purchase Agreement, dated August 15, 2024, by and between the Company and the Sponsor. 10.3(b) Private Placement Warrants Purchase Agreement, dated August 15, 2024, by and between the Company and the Underwriter. 10.4 Letter Agreement, dated August 15, 2024, by and among the Company, its officers, its directors and the Sponsor. 10.5 Administrative Support Agreement, dated August 15, 2024, between the Company and the Sponsor. 99.1 Press Release, dated August 15, 2024. 99.2 Press Release, dated August 19, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HCM II Acquisition Corp. By: /s/ Shawn Matthews Name: Shawn Matthews Title: Chairman and Chief Executive Officer Dated: August 20, 2024

View Full Filing

View this 8-K filing on SEC EDGAR